Evaluating results from the multiple myeloma subset of patients treated with denosumab or zoledronic acid (ZA) in a randomized phase III study.
Noopur S. Raje
Consultant or Advisory Role - Celgene; Millennium; Novartis; Onyx
Research Funding - Acetylon Pharmaceuticals; Amgen; Lilly
Wolfgang Willenbacher
Consultant or Advisory Role - Amgen
Honoraria - Amgen
Vania Hungria
No relevant relationships to disclose
Andrew Spencer
No relevant relationships to disclose
Yulia Alexeeva
No relevant relationships to disclose
Thierry Facon
Consultant or Advisory Role - Amgen
A. Keith Stewart
Consultant or Advisory Role - Amgen
Honoraria - Amgen
Research Funding - Novartis
David Roodman
Consultant or Advisory Role - Amgen
Evangelos Terpos
Consultant or Advisory Role - Amgen
Honoraria - Amgen; Novartis
Amy Feng
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Ada Braun
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Arun Balakumaran
Employment or Leadership Position - Amgen
Stock Ownership - Amgen